Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) perioperative treatment regimen has been recommended by the European Medicines Agency’s human medicines committee for adults with ...

BeiGene’s Tevimbra (tislelizumab) has been recommended by the European Medicines Agency’s human medicines committee as part of a first-line combination treatment for an aggressive form of lung cancer.

Organon and Shanghai Henlius Biotech have announced that the European Medicines Agency (EMA) has validated a marketing authorisation application for HLX11, a biosimilar candidate referencing Roche’s ...

In advanced stages, people with ALS may lose the ability to stand, walk, independently get in and out of bed, use their hands ...

We found that most respondents had a positive perception of gene therapy, with 37% rating their perception as ‘very positive’ ...

Prime Global- The medical communications people. Prime Global is a group of six full-service medical communications agencies and specialist consultancies. We provide the world’s leading biotech, ...

AstraZeneca (AZ) has announced that its Imfinzi (durvalumab) perioperative regimen has been approved by the US Food and Drug ...

Novartis’ radioligand therapy Pluvicto (lutetium Lu 177 vipivotide tetraxetan) has been approved by the US Food and Drug ...

Pfizer’s respiratory syncytial virus (RSV) vaccine has been approved by the European Commission (EC) to prevent RSV-associated lower respiratory tract disease (LRTD) in individuals aged 18 to 59 years ...

OPEN Health has announced the appointment of Matt D’Auria as its new chief executive officer (CEO). D’Auria brings more than ...

While AI tools offer undeniable benefits, they also risk diminishing our engagement in deep, reflective thinking and learning ...

SCRIP Intelligence is the leading source of news and strategic analysis for the global pharmaceutical industry. We filter the flood of information on the industry and apply the knowledge of our ...